SWITCHING OF BIOLOGICAL DRUGS IN RHEUMATOID ARTHRITIS: A COHORT OF USERS FROM THE BRAZILIAN PUBLIC HEALTH SYSTEM

被引：0
|
作者：
Matute, D. L. [1 ]
Galvao, T. F. [2 ]
Mota, L. M. [3 ]
Pereira, M. G. [3 ]
Silva, M. T. [4 ]
机构：
[1] Univ Fed Amazonas, Manaus, Amazonas, Brazil
[2] Univ Estadual Campinas, Campinas, SP, Brazil
[3] Univ Brasilia, Brasilia, DF, Brazil
[4] Univ Sorocaba, Sorocaba, Brazil
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.2984
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS25
引用
收藏
页码：A939 / A939
页数：1
相关论文
共 50 条
  • [41] BIOLOGICAL TREATMENT SWITCHING AND WITHDRAWAL: A REVIEW OF RHEUMATOID ARTHRITIS GUIDELINES
    Piazza, T.
    Tonin, F.
    Wiens, A.
    Pontarolo, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1059 - 1059
  • [42] Risk Factors and Diagnosis of Diabetic Foot Ulceration in Users of the Brazilian Public Health System
    Cardoso, Higor Chagas
    Amancio Zara, Ana Laura de Sene
    Rodrigues Fleury Rosa, Suelia de Siqueira
    Rocha, Gabriel Alves
    Costa Rocha, Joao Victor
    Emos de Araujo, Maria Clara
    Quinzani, Pedro de Freitas
    Barbosa, Yaman Paula
    Mrue, Fatima
    JOURNAL OF DIABETES RESEARCH, 2019, 2019
  • [43] Access to medicines in the public sector: analysis of users of the Brazilian Unified National Health System
    Boing, Alexandra Crispim
    Bertoldi, Andrea Damaso
    Boing, Antonio Fernando
    Bastos, Joao Luiz
    Peres, Karen Glazer
    CADERNOS DE SAUDE PUBLICA, 2013, 29 (04): : 691 - 701
  • [44] The treatment of diabetic macular edema with intravitreal bevacizumab in users of the Brazilian public health system
    Ibrahim, Larissa Fouad
    Soares, Aleida Nazareth
    Costa, Lucas Assis
    Domingues, Thabata Machado Correia
    Souza, Alessandra Hubner de
    ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2024, 87 (05)
  • [45] Budget impact analysis of abatacept inclusion for moderate to severe rheumatoid arthritis in the Brazilian public system
    Alves, M. R.
    Carvalho, F., Jr.
    Litalien, G.
    VALUE IN HEALTH, 2008, 11 (03) : A256 - A256
  • [46] ORAL ANTIDIABETIC DRUG THERAPY COMPLIANCE AMONG BRAZILIAN PUBLIC HEALTH SYSTEM USERS
    Moura de Araujo, Marcio Flavio
    Junior Freire de Freitas, Roberto Wagner
    Carvalhedo Fragoso, Luciana Vladia
    de Araujo, Thiago Moura
    Coelho Damasceno, Marta Maria
    Zanetti, Maria Lucia
    TEXTO & CONTEXTO ENFERMAGEM, 2011, 20 (01) : 135 - 143
  • [47] Utilization of biological drugs for the treatment of rheumatoid arthritis in Tuscany, Italy
    Roberto, Giuseppe
    Bardelli, Filippo
    Bartolini, Claudia
    Gini, Rosa
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 276 - 277
  • [48] Synthesis and Biological Activities of Chemical Drugs for the Treatment of Rheumatoid Arthritis
    Shiyang Zhou
    Huiying Zou
    Guangying Chen
    Gangliang Huang
    Topics in Current Chemistry, 2019, 377
  • [49] Advances in non-biological drugs for the treatment of rheumatoid arthritis
    Venetsanopoulou, Aliki I.
    Voulgari, Paraskevi V.
    Drosos, Alexandros A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (01) : 45 - 53
  • [50] Synthesis and Biological Activities of Chemical Drugs for the Treatment of Rheumatoid Arthritis
    Zhou, Shiyang
    Zou, Huiying
    Chen, Guangying
    Huang, Gangliang
    TOPICS IN CURRENT CHEMISTRY, 2019, 377 (05)
12345